asthma pharmacology

Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial
Rubén Andújar-Espinosa, Lourdes Salinero-González, Fátima Illán-Gómez, Manuel Castilla-Martínez, Chunshao Hu-Yang, Francisco José Ruiz-López

Thorax Feb 2021, 76 (2) 126-133; DOI: 10.1136/thoraxjnl-2019-213936
Add-on azithromycin reduces sputum cytokines in non-eosinophilic asthma: an AMAZES substudy
Shakti D Shukla, Steven L Taylor, Peter G Gibson, Daniel Barker, John W Upham, Ian A Yang, Paul N Reynolds, Sandra Hodge, Alan L James, Geraint B Rogers, Jodie L Simpson

Thorax Jan 2021, thoraxjnl-2020-216331; DOI: 10.1136/thoraxjnl-2020-216331
Risk of osteoporosis and fragility fractures in asthma due to oral and inhaled corticosteroids: two population-based nested case-control studies
Christos V Chalitsios, Dominick E Shaw, Tricia M McKeever

Thorax Jan 2021, 76 (1) 21-28; DOI: 10.1136/thoraxjnl-2020-215664
Association between asthma, corticosteroids and allostatic load biomarkers: a cross-sectional study
Luke Evan Barry, Ciaran O’Neill, Liam G Heaney

Thorax Oct 2020, 75 (10) 835-841; DOI: 10.1136/thoraxjnl-2019-214139
What matters most to patients when choosing treatment for mild–moderate asthma? Results from a discrete choice experiment
Christina Baggott, Paul Hansen, Robert J Hancox, Jo Katherine Hardy, Jenny Sparks, Mark Holliday, Mark Weatherall, Richard Beasley, Helen K Reddel, James Fingleton

Thorax Oct 2020, 75 (10) 842-848; DOI: 10.1136/thoraxjnl-2019-214343
CEACAM3 decreases asthma exacerbations and modulates respiratory syncytial virus latent infection in children
Ching-Hui Tsai, Ann Chen Wu, Bor-Luen Chiang, Yao-Hsu Yang, Shih-Pin Hung, Ming-Wei Su, Ya-Jen Chang, Yungling L Lee

Thorax Sep 2020, 75 (9) 725-734; DOI: 10.1136/thoraxjnl-2019-214132
Carbon footprint impact of the choice of inhalers for asthma and COPD
Christer Janson, Richard Henderson, Magnus Löfdahl, Martin Hedberg, Raj Sharma, Alexander J K Wilkinson

Thorax Jan 2020, 75 (1) 82-84; DOI: 10.1136/thoraxjnl-2019-213744
Change in type-2 biomarkers and related cytokines with prednisolone in uncontrolled severe oral corticosteroid dependent asthmatics: an interventional open-label study
John Busby, Cecile T J Holweg, Akiko Chai, Peter Bradding, Fang Cai, Rekha Chaudhuri, Adel H Mansur, James Laurence Lordan, John G Matthews, Andrew Menzies-Gow, Robert Niven, Tracy Staton, Liam G Heaney

Thorax Aug 2019, 74 (8) 806-809; DOI: 10.1136/thoraxjnl-2018-212709
Duration of the efficacy of omalizumab after treatment discontinuation in ‘real life’ severe asthma
Maria del Carmen Vennera, Carlos Sabadell, Cesar Picado

Thorax Aug 2018, 73 (8) 782-784; DOI: 10.1136/thoraxjnl-2017-210017
Morbidity associated with oral corticosteroids in patients with severe asthma
Xue Ning Choo, Ian D Pavord

Thorax Apr 2016, 71 (4) 302-304; DOI: 10.1136/thoraxjnl-2015-208242

Main menu

asthma pharmacology

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

asthma pharmacology

Pages